ARA 290 16mg

ARA-290, also known as Cibinetide, is a synthetic peptide derived from erythropoietin (EPO) that has been specifically engineered to activate tissue-protective pathways without stimulating red blood cell production.
 
Unlike full EPO, ARA-290 selectively targets the innate repair receptor (IRR), a pathway studied for its role in cellular protection, inflammation modulation, and nerve signaling support, while avoiding hematologic effects associated with erythropoiesis.
 
ARA-290 has been researched for its potential involvement in neuropathic signaling, inflammatory response regulation, and tissue recovery mechanisms, making it of interest in advanced wellness and research settings focused on recovery and nervous system support.
 
This product is supplied in a 16mg lyophilized vial and is intended for research and professional use only, under appropriate clinical oversight.
 
Key Characteristics:
 
EPO-derived peptide without erythropoietic activity
Targets tissue-protective and repair signaling pathways
Studied for inflammation modulation and nerve-related support
Does not increase red blood cell production
Supplied in lyophilized form
 
Important Notice:
This product is not intended to diagnose, treat, cure, or prevent any disease. Intended for use by qualified professionals in accordance with applicable regulations.